HHS Cuts Funding for American Academy of Pediatrics' Programs

The U.S. government has ended several health grants to one of the nation’s largest pediatricians’ groups, a move the organization says could hurt children and families across the country.

The American Academy of Pediatrics (AAP) confirmed this week that the U.S. Department of Health and Human Services (HHS) is canceling seven f...

FDA May Reduce How Often Supplement Warnings Appear on Labels

The U.S. Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

Unlike prescription drugs, dietary supplements are not reviewed by the FDA for safety or effectiveness before they are sold.

Instead, a 1994 federal law requires companies to include a...

Study Finds Cancer-Linked Chemicals in Some Firefighter Gear

Some protective gear worn by firefighters may contain chemicals linked to serious health risks, according to a new study.

The research — published Dec. 16 in the journal Environmental Science & Technology Letters — found that certain firefighter turnout gear contains brominated flame retardants, or chemicals added ...

Nerve Block Cuts Opioids Needed Following Cleft Palate Surgery

Using a nerve blocker before surgery to correct cleft palate can reduce or eliminate the need to prescribe infants opioids to manage post-procedure pain, a new study says.

A nerve block administered to a nerve that provides sensation to the palate, upper jaw and upper lip  halts pain during the surgery and significantly reduces it aft...

Different Mental Health Conditions Share Similar Genetics, Study Says

Psychiatric conditions as varied as schizophrenia and bipolar disorder might be driven by very similar genetic underpinnings, a new study says. 

Mental health problems can be sorted into five general genetic categories, each with a shared “genetic architecture” driving people’s illness, according to results published...

Eczema Injectable Drug Provides Quick Itch Relief, Clinical Trial Results Show

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says.

Nemolizumab (Nemluvio) relieved itchiness within two days for three times as many patients as a placebo, researchers reported Dec. 16 in the Journal of the European Academy of Dermatology and Venereology<...